UK markets closed

Allogene Therapeutics, Inc. (ALLO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.4300-0.0300 (-0.87%)
As of 03:44PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts15151614
Avg. Estimate-0.41-0.4-1.65-1.57
Low estimate-0.64-0.54-2.1-2.2
High estimate-0.22-0.23-0.91-0.24
Year ago EPS-0.68-0.53-2.09-1.65
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts10101310
Avg. Estimate10k10k40k6.11M
Low estimateN/AN/AN/AN/A
High estimate50k50k200k60.97M
Year ago sales52k44k95k40k
Sales growth (year/est)-80.80%-77.30%-57.90%15,175.00%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.62-0.59-0.52-0.45
Actual EPS-0.68-0.53-0.37-0.51
Difference-0.060.060.15-0.06
Surprise %-9.70%10.20%28.80%-13.30%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.41-0.4-1.65-1.57
7 days ago-0.41-0.4-1.66-1.54
30 days ago-0.41-0.4-1.69-1.62
60 days ago-0.44-0.42-1.76-1.83
90 days ago-0.45-0.44-1.78-1.81
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/A11
Up last 30 daysN/AN/A12
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesALLOIndustrySector(s)S&P 500
Current qtr.39.70%N/AN/AN/A
Next qtr.24.50%N/AN/AN/A
Current year21.10%N/AN/AN/A
Next year4.80%N/AN/AN/A
Next 5 years (per annum)1.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A